Skip to main content
. 2012 Jul 2;3:31–41. doi: 10.2147/LCTT.S16442

Figure 1.

Figure 1

Frequency of gene mutations in non-small cell lung cancer (NSCLC).

Note: The most commonly identified mutations are in the epidermal growth factor receptor (EGFR) gene and the Kirsten ras (KRAS) gene, with a large number of patients still without identifiable targets for therapy.

Abbreviations: ALK, anaplastic lymphoma kinase; HER2, human epidermal growth factor receptor 2; MET, mesenchymal-epithelial transition; PIK3CA, phosphoinositide-3-kinase, catalytic, alpha polypeptide.